Can you afford to miss these two cheap growth stocks?

Here are two of the stocks one of the UK’s top growth funds is betting on.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The AXA Framlington UK Mid Cap fund is one of the UK’s best performing equity funds. Over the past five years, the fund has returned a total of 139.2% compared to 71.1% for the UK All Companies Index.

Chris St John, who has managed the fund since 2011, knows how to pick small and mid-cap growth stocks. His equity picks over the years have helped the fund achieve these lofty gains, although there has also been a healthy dose of volatility along the way.

Still, despite the volatility, over the long-term the strategy has clearly yielded results. So, which companies is the AXA Framlington UK Mid Cap betting on right now?

Profits from plastic 

The fund’s top holding, coming in at 3.4% of the equity portfolio, is RPC Group (LSE: RPC). RPC is plastics packaging business, a relatively boring business that flies under the radar of most investors. 

RPC’s business may be boring, but the company is extremely good at it. Since 31 March 2012, the end of the company’s 2012 financial year, revenue has expanded from £1.1bn to £1.6bn. Pre-tax profit has grown by around a third over the same period and earnings per share have risen from 31p to 43.3p.

Next year RPC’s growth is expected to take off following yesterday’s news of two acquisitions, which are set to transform the business. 

First off RPC is buying ESE World B.V., for a consideration of €262m. ESE is Europe’s largest temporary waste storage solutions provider, with targeted revenues of €200m for 2016. The second acquisition is Astrapak, a leading South African manufacturer of rigid plastic packaging products and components. RPC is paying 1,370m Rand for the business (around £79m).

After these acquisitions, City analysts are now expecting RPC to report earnings per share growth of 39% for the financial year ending 31 March 2017, with earnings per share growth of 14% in the year after. Based on these figures, shares in RPC look undervalued to me. Specifically, the shares are currently trading at a forward P/E multiple of 17.5 and a PEG ratio of 0.4. A PEG ratio of less than one indicates the shares in question may offer growth at a reasonable price.

Growth at a reasonable price 

Another of the AXA’s funds top holdings is online payments processor Paysafe (LSE: PAYS). Shares in Paysafe lost more than 30% of their value at one point earlier this week, when US firm Spotlight Research issued a damning report on the company claiming the business was facilitating illegal gambling in China and faces “material risks” from regulatory action. The research outfit also claimed that up to 50% of Paysafe’s revenues were in danger. Paysafe’s management has responded to these allegations by stating that all information was “either factually inaccurate or had previously been disclosed.” Since this rebuttal, shares in the company have recovered.

That said, even after the recovery, shares in the company still look cheap to me. Paysafe is expected to report a pre-tax profit of £168m this year, up from £11.8m last year. The City is expecting the company to report earnings per share of just under 32p, which translates into a forward P/E of 11.7. Next year earnings per share growth of 14% is pencilled in. This kind of growth may be too hard for some investors to pass up. 

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended RPC Group. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »